7-n-(4-hydroxyphenyl)mitomycin c has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, R; Inaba, M; Kobayashi, T; Marumo, H; Morimoto, M; Sakurai, Y; Tsukagoshi, S; Tsuruo, T | 1 |
| Hoshi, A; Kanzawa, F; Matsushima, Y; Miyazawa, N; Saijo, N; Shimizu, E | 1 |
2 other study(ies) available for 7-n-(4-hydroxyphenyl)mitomycin c and Carcinoma
| Article | Year |
|---|---|
Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems.
Topics: Animals; Carcinoma; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrosarcoma; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Mitomycin; Mitomycins; Neoplasms, Experimental; Sarcoma 180 | 1981 |
Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Colony-Forming Units Assay; Drug Evaluation; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Tumor Stem Cell Assay | 1985 |